John A. Sedor

John A. Sedor discloses dealings in Pernix Therapeutics Holdings, Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 3 November 2016 to 8 August 2018.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 10 August 2018: a share grant of €1,097, in Pernix Therapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.